PHK
CERE

Point72 Hong Kong’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Point72 Hong Kong’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,470
Closed -$42K – 1324
2022
Q3 		$42K Buy
+1,470
New +$42K ﹤0.01% 945
2022
Q1 		– Sell
-4,702
Closed -$152K – 1908
2021
Q4 		$152K Sell
4,702
-3,814
-45% -$123K 0.01% 534
2021
Q3 		$251K Buy
+8,516
New +$251K 0.01% 528